Clinical Trial Update: Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether escitalopram helps prevent or reduce depressive symptoms in people receiving interleukin-2 treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Emory University | Conditions: Depression | Phase 4 | Status: COMPLETED | Results posted: 2014-06-27